Other Information
−Removed: Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated April 3 0 , 202 6 , by Ro bert D.
−Removed: Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated April 3 0 , 202 6 , by Natasha Fernandes
−Removed: Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated April 3 0 , 202 6 , by R obert D.
−Removed: Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated April 3 0 , 202 6 , by Natasha Fernandes
+Added: (c) Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements.
+Added: On May 19, 2026, Richard Gelfond, the CEO, entered into a Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K under the Exchange Act (“Item 408”) and such arrangement, the “Gelfond Plan”) for the exercise of 356,757 of stock options granted in June 2016 (the “Options”) and sale of up to 356,757 common shares underlying the Options.
+Added: The Options have a 10-year
+Added: expiry and are due to expire on January 3, 2027.
+Added: Sales under this Gelfond Plan, which was previously disclosed in a Company subsidiary filing, may commence on August 18, 2026, after the completion of the required cooling off period under Rule 10b5-1.
+Added: The Gelfond Plan will terminate on December 31, 2026, or earlier if all shares underlying the Options have been sold.
+Added: This trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: On June 26, 2026, Natasha Fernandes, the Company’s Chief Financial Officer, entered into a Rule 10b5-1 trading arrangement (as defined in Item 408) and such arrangement, the “Fernandes Plan”) for the sale of up to 30,000 common shares of the Company.
+Added: Sales under the Fernandes Plan may commence on September 24, 2026, after the completion of the required cooling off period under Rule 10b5-1.
+Added: The Fernandes Plan will terminate on March 1, 2027, or earlier if all shares under the Fernandes Plan have been sold.
+Added: This trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: No other Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as defined in Item 408) were adopted or terminated by any directors or officers of the Company during the second quarter of 2026.
+Added: Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated July 23, 2026, by Richard L.
+Added: Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated July 23, 2026, by Natasha Fernandes
+Added: Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated July 23, 2026, by Richard L.
+Added: Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated July 23, 2026, by Natasha Fernandes
101.INS Inline XBRL Instance Document – The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.
9 unchanged sentences
IMAX CORPORATION
−Removed: April 30, 2026
+Added: July 23, 2026
/s/ NATASHA FERNANDES
2 unchanged sentences
(Principal Financial Officer)
−Removed: April 30, 2026
+Added: July 23, 2026
/s/ JOSE ZLATAR
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.